The global neurofeedback systems market size was valued at USD 1,070 million in 2021. It is expected to reach USD 1,940 million by 2030, growing at a CAGR of 7.72% during the forecast period (2022–2030).
Neurofeedback describes either positive or negative biofeedback resulting from healthy or unhealthy brain functions. Neurofeedback is biofeedback that teaches people to self-regulate brain activities by detecting brain waves and generating a feedback signal. Typically, audio and/or visual input is provided using this method. Brain activities that are desirable or undesired are accompanied by positive or negative feedback. Electroencephalography (EEG) is a tool used in neurofeedback, or Neurotherapy, to track brain activity and offer real-time feedback via sounds and visuals. The central nervous system is the main target of neurofeedback therapy, which aims to improve neurological regulation. Neurofeedback therapy can be highly successful for various mental health conditions, including post-traumatic stress disorder, attention deficit hyperactivity disorder, and obsessive-compulsive disorder. Even people with catastrophic brain injuries can benefit from it.
Neurofeedback therapy has been the subject of numerous studies to see how well it works in treating various brain-related illnesses. The neurofeedback system can be used to treat a variety of brain disorders, including epilepsy, pain, and anxiety disorders. Enhancing relaxation and triggering self-regulation are two crucial elements of healthy brain function that are both facilitated by the neurofeedback system. Neurofeedback systems also consider behavioral, cognitive, and subjective factors to record brain activity more accurately. Due to its alternative and complementary treatment for various brain dysfunctions, rising demand for non-invasive treatment protocols, and increased prevalence of several neurological disorders in recent years, neurofeedback systems are expected to experience favorable growth in the global market throughout the forecast period.
|Market Size||USD 1,940 million by 2030|
|Fastest Growing Market||Europe|
|Largest Market||North America|
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends|
The primary drivers of the global neurofeedback systems market are the rising prevalence of neurodegenerative diseases worldwide, technical advancements, expanding research and development activities in the relevant market, rising investment, and increasing product releases. Nearly 30,000 Americans were living with Huntington's disease in 2019, and another 200,000 were at risk of contracting the disorder, according to the National Organization for Rare Disorders (NORD). The patient's functional capacities are affected by this illness, which typically causes mobility, cognitive, and psychological issues. Therefore, in certain neurodegenerative diseases, brain monitoring is necessary. The increasing frequency of these illnesses will thus fuel the market.
Increased technological developments and product releases will also drive a large portion of the market growth. For instance, a neurofeedback system called Explorer was introduced by Naxon Labs in May 2020 for engineering, information technology, neuroscience, and medical experts. Bluetooth connectivity allows this technology to display the brain wave frequencies in real time on any output device. Technological advancements will change how neurodegenerative illnesses are treated, expanding the market. Additionally, neurofeedback systems need more time and have high device costs, which are anticipated to limit market growth throughout the projection period.
The increasing prevalence of neurological disorders, stress, and other illnesses that have an impact on or alter brain function in one way or another are mostly to blame for brain dysfunction. For instance, according to a study by Charles M. Morin and published in the JAMA Network Open Journal in November 2020, approximately 13.9% of good initial sleepers acquired an insomnia condition throughout the 5-year follow-up period, with incidence rates being about 17.7% higher among women than men. The long-term adverse effects of chronic insomnia may significantly affect the prognosis and treatment of insomnia. Moreover, a high comorbidity rate between sleeplessness and specific medical or psychiatric problems has been noted. These numbers are a direct result of the population's current lifestyle-related increase in stress, which is anticipated to fuel the demand for neurofeedback systems.
Neurofeedback is a technique that helps people consciously control their brain waves, and neurofeedback systems are the tools that help people do that. However, these tools or procedures are costly and time-consuming, which is assumed to limit the growth of the researched market for neurofeedback systems globally. The most expensive neurofeedback training systems range in price from USD 7,000 for a home system to over USD 10,000 for a professional one, and programs to be rented and used at home may cost between USD 600 and USD 900 per month, depending on the number of sessions and family members training, which further drives up the cost. As a result, the high price associated with neurofeedback systems is expected to restrain the market's growth over the long term.
The development of new products is facilitated by technology and its expanding applications in the healthcare industry. Future results are anticipated to increase in the market for neurofeedback systems. The burden of neurological dysfunction is predicted to grow globally, which is expected to be accompanied by a rise in the need for novel goods that will map anxiety and stress in the future. The European Commission's Brain/Neural Computer Interaction Horizon 2020 project aims to coordinate research on brain-computer interfaces with six main applications: restoration, replacement, enhancement, supplementation, improvement, and as a research tool. The project has six main application themes: improving, augmenting, restoring, replacing, enhancing, and as a research tool. The neurofeedback systems market is anticipated to grow due to this project's potential to ease the lives of individuals with neurodegenerative illnesses.
Region-wise, the global neurofeedback market includes North America, Europe, Asia-Pacific, South America, and the Middle East and Africa.
North America will command the maximum market share, expanding at a CAGR of 7.9% over the forecast period. North America essentially drives the growth of this market due to its sophisticated healthcare infrastructure and numerous medical device businesses that are well-connected with hospitals. Since many companies choose to conduct their clinical advancement efforts in developed markets, primarily the United States, North America is also the region that has contributed most to the market's expansion. The increased incidence of the target diseases in this area is a significant factor fueling the market's growth. Up to 20% of Americans have insomnia each year, according to the American Academy of Sleep Medicine 2020.
Behavioral insomnia affects 30% of children and is particularly common in children with poor sleep habits. Additionally, 40 million Americans aged 18 and older may experience an anxiety illness each year in 2020, according to the Anxiety and Depression Disorders Association of America (ADAA). Thus, this region's high prevalence of insomnia and anxiety disorders promotes the demand for neurofeedback systems, fueling the market's expansion. The introduction of new products by numerous firms also contributes to the market's growth. For instance, in 2019, Narbis made its brand-exclusive Narbis smart glasses available. These glasses use neurofeedback principles and a NASA-developed algorithm to boost concentration and decrease drowsiness while reading, using a computer, studying, or doing online assignments. The market for neurofeedback systems is also fueled by numerous foundations, which serve as support networks for numerous healthcare professionals involved in treating brain dysfunctions.
Europe will likely generate USD 529 million, growing at a CAGR of 7.3% over the forecast period. One of the biggest neurofeedback markets in Europe is Germany, and it is anticipated to develop significantly during the projection period. The market in Germany is expanding due to factors including the rising incidence of chronic diseases, the aging population, the increasing demand for efficient products, and beneficial initiatives by the major industry participants. According to the Alzheimer Europe 2019 study, there were around 1,585,166 dementia sufferers in Germany in 2018; by 2050, this number is expected to increase to 2,748,178. Similarly, the proportion of people with dementia in the general population will increase from 1.91% in 2018 to 3.43% in 2050. In the upcoming years, it's anticipated that there will be an increase in dementia cases, which will benefit the market. Dementia and other neurological illnesses are treated with the neurofeedback system. So, this is anticipated to promote market expansion.
The global neurofeedback systems market is classified based on type, application, and region.
The global neurofeedback systems market includes Frequency Neurofeedback, Low Energy Neurofeedback, Slow Cortical Potential Neurofeedback, Hemoencephalographic Neurofeedback, Low-Resolution Electromagnetic Tomography, and Functional Magnetic Resonance Imaging Systems.
The Frequency Neurofeedback system section is projected to advance significantly and hold the largest market share over the forecast period. Its popularity among neurologists and convenience and simplicity of operation are the main characteristics promoting its good growth. Surface neurofeedback is commonly referred to because it uses 2 to 4 surface electrodes. It alters the amplitude and frequency of certain brain waves to treat neurological conditions like ADHD, sleeplessness, and anxiety.
The global neurofeedback systems market includes Attention Deficit Hyperactivity Disorder (ADHD), Pain Management, Insomnia, Anxiety Disorder, and Other Diseases.
The ADHD section is projected to advance at a CAGR of 8.2% and hold the largest market share over the forecast period. The most prevalent neurodevelopmental illness in children is attention deficit hyperactivity disorder (ADHD). It frequently persists into maturity and is typically first diagnosed in infancy. Patients with ADHD, especially children, may struggle to regulate impulsive behavior, pay attention, or stop being overly active. The expanding emphasis on neurofeedback therapy, equipment research and development, and the increasing prevalence of ADHD globally are two significant drivers driving the segment's rise. Additionally, the increased emphasis on research and development is creating robust neurofeedback systems, boosting the industry.
The Insomnia section will hold the second-largest share. Insomnia is a common sleep problem that can make it difficult to fall asleep, difficult to stay asleep or cause early awakening and difficulties falling back asleep. After waking up, those who have insomnia could still feel exhausted. The main drivers of market expansion are the prevalence of insomniacs, the execution of strategic efforts by market participants, and the increased emphasis on the study and creation of neurofeedback systems for sleep disorders. The market is expanding due to the increased usage of neurofeedback devices for treating insomnia and the increased focus on research and development of neurofeedback systems.